sorafenib has been researched along with cryptotanshinone in 3 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (cryptotanshinone) | Trials (cryptotanshinone) | Recent Studies (post-2010) (cryptotanshinone) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 370 | 0 | 268 |
| Protein | Taxonomy | sorafenib (IC50) | cryptotanshinone (IC50) |
|---|---|---|---|
| Chain A, RNA-directed RNA polymerase NS5 | Dengue virus 2 16681-PDK53 | 90.06 | |
| Lysine-specific histone demethylase 1A | Homo sapiens (human) | 9.02 | |
| Replicase polyprotein 1a | Severe acute respiratory syndrome-related coronavirus | 0.8 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 3.722 | |
| Indoleamine 2,3-dioxygenase 1 | Homo sapiens (human) | 10 | |
| Signal transducer and activator of transcription 3 | Homo sapiens (human) | 4.6 | |
| Tryptophan 2,3-dioxygenase | Homo sapiens (human) | 9.8 | |
| Hypoxia-inducible factor 1-alpha | Homo sapiens (human) | 1.47 | |
| Endothelial PAS domain-containing protein 1 | Homo sapiens (human) | 1.47 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, XG; Du, TT; Ji, M; Li, L; Liu, WQ; Liu, YC; Wang, R; Yang, BB; Yang, YD | 1 |
| Huang, K; Liu, CH; Liu, HL; Lü, J; Sun, X; Tao, YY; Zhao, ZM | 1 |
| Fu, J; Han, S; Jia, Q; Lin, Y; Lv, Y | 1 |
3 other study(ies) available for sorafenib and cryptotanshinone
| Article | Year |
|---|---|
Benzobis(imidazole) derivatives as STAT3 signal inhibitors with antitumor activity.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Humans; Imidazoles; Liver Neoplasms; Mice; Mice, Nude; Phosphorylation; STAT3 Transcription Factor; Xenograft Model Antitumor Assays | 2022 |
[Evaluation of cryptotanshinone inhibition of angiogenesis in human hepatic sinusoidal endothelial cells].
Topics: Animals; Animals, Genetically Modified; Cell Proliferation; Cells, Cultured; Down-Regulation; Drugs, Chinese Herbal; Endothelial Cells; Humans; Neovascularization, Pathologic; Niacinamide; Nitric Oxide; Phenanthrenes; Phenylurea Compounds; Salvia miltiorrhiza; Sorafenib; von Willebrand Factor; Zebrafish | 2016 |
Dual-mixed/CMC model for screening target components from traditional Chinese medicines simultaneously acting on EGFR & FGFR4 receptors.
Topics: Abietanes; Alkenes; Cell Proliferation; Chromatography, High Pressure Liquid; Drugs, Chinese Herbal; ErbB Receptors; Gefitinib; HEK293 Cells; Humans; Phenanthrenes; Polyphenols; Protein Kinase Inhibitors; Receptor, Fibroblast Growth Factor, Type 4; Salvia miltiorrhiza; Sorafenib; Spectrometry, Mass, Electrospray Ionization | 2019 |